Social Capital and Financial Toxicity in Caregivers of Patients With Advanced Cancer: Associations With Health-Related Quality of Life and Psychological Distress [0.03%]
晚期癌症患者的照顾者中的社会资本与金融毒性：与健康相关的生活质量和心理压力的关系
Jin-Ah Sim,Danyu Kim,Shin Hye Yoo et al.
Jin-Ah Sim et al.
Background: Informal caregivers of patients with advanced cancer face increasing psychosocial and financial burdens; however, their health-related needs remain underrecognized. Although prior studies have examined social ...
Perioperative Systemic Treatment Options for Muscle-Invasive Bladder Cancer [0.03%]
肌侵袭性膀胱癌围手术期全身治疗的选择
Jason R Brown,Mamta Parikh
Jason R Brown
Radical cystectomy has long been the standard of care for muscle-invasive bladder cancer (MIBC), an aggressive cancer with a high risk of progression to recurrent or metastatic disease. Systemic therapy has improved survival outcomes for th...
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas [0.03%]
法国ENDOCAN-COMETE联盟对罕见肾上腺皮质癌总生存率的影响
Rossella Libé,Matthieu Faron,Anne-Sophie Foucan et al.
Rossella Libé et al.
Background: Adrenocortical carcinoma (ACC) is a rare cancer. The French ENDOCAN-COMETE network was established in 2009 to coordinate care locally and nationally, and to promote research and education on malignant adrenal ...
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial [0.03%]
静脉注射患者控制性镇痛与口服阿片类药物维持重度癌痛的疗效比较：一项三期随机临床试验
Rongbo Lin,Lang He,Mingqian Lu et al.
Rongbo Lin et al.
Background: Effective management of severe cancer pain remains challenging. Our phase II study suggested that intravenous patient-controlled analgesia with hydromorphone (IPCA-HM), delivered either as bolus-only or contin...
Preoperative Stereotactic Body Radiotherapy for Metastatic Bone Disease With Impending Fracture: A Nonrandomized Clinical Trial [0.03%]
术前立体定向体放射治疗伴有病理性骨折风险的骨转移瘤：非随机临床试验
Max Vaynrub,Meredith K Bartelstein,Victoria Y Yu et al.
Max Vaynrub et al.
Background: Surgical stabilization followed by postoperative radiotherapy (RT) is the standard of care for impending pathologic fractures due to bone metastases. Compared with conventional RT, stereotactic body RT (SBRT) ...
Targeted Therapy for Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood [0.03%]
儿童全身性EB病毒阳性T细胞淋巴瘤的靶向治疗
Jonathan J Holzmann,Michael O&#x;Sullivan,Adrian Charles et al.
Jonathan J Holzmann et al.
Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood (STCLC) is a rare and highly aggressive malignancy with a dismal prognosis and no standard curative treatment. This report describes the first reported case of STCLC in a Whi...
Safely Stopping Premedications in Patients Receiving Paclitaxel: A Randomized Trial [0.03%]
紫杉醇患者安全停用预用药的随机试验
Michael Berger,Maryam Lustberg,Paul J Novotny et al.
Michael Berger et al.
Background: Premedications used to prevent paclitaxel-associated infusion hypersensitivity reactions (iHSRs) can cause undesirable toxicities, such as sleep disturbance and weight gain. Although phase II data suggest that...
Acquired Resistance to Immune Checkpoint Inhibitors Across Tumor Types: A Reconstructed Individual Patient Data Analysis [0.03%]
基于重建的个体患者数据对不同肿瘤类型中免疫检查点抑制剂获得性耐药性的分析
Yago Garitaonaindia,Rikke Andersen,Mario Presti et al.
Yago Garitaonaindia et al.
Background: Some patients with cancer who initially benefit from checkpoint inhibitors (CPIs) achieve lasting remission or cure. Acquired resistance to immunotherapy (ARI) refers to disease progression occurring after an ...
BPI26-006: Too Late to Test: Real-World Impact of MSI/MMR Testing Delays on Survival and Treatment in Colorectal Cancer [0.03%]
MSI/MMR检测延迟的现实世界影响：对结直肠癌患者生存和治疗的影响不容忽视
Chiugo Okoye,Chinemerem Emeasoba,Chidi Obialo-Ibeawuchi et al.
Chiugo Okoye et al.
BPI26-012: Addressing the Demand for Cancer Germline Testing with Attention to Standard-of-Care: Interim Results From an EMR-Embedded Point-of-Care Genetic Testing Pathway [0.03%]
基于EMR的肿瘤遗传咨询及基因检测门诊模式初步分析
Kathryn Mason,Claire Healy,Carson Nestler et al.
Kathryn Mason et al.